Randomized Trial of Cognitive-Behavioral Therapy Versus Light Therapy for Seasonal Affective Disorder: Acute Outcomes.
Study Goal
The researchers aimed to compare the effectiveness of cognitive-behavioral therapy for SAD (CBT-SAD) and light therapy in treating acute episodes of seasonal affective disorder.
Results Summary
Light therapy significantly improved depression severity, with comparable efficacy to CBT-SAD, as measured by SIGH-SAD and BDI-II scores. Remission rates were similar for both treatments (47.2% for light therapy based on SIGH-SAD and 63.6% based on BDI-II).
Population
177 adults with recurrent major depression exhibiting a seasonal pattern.
Effective Dosage
10,000-lux cool-white fluorescent light, initiated at 30 minutes each morning and adjusted based on response and side effects.
Duration
6 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
CBT-SAD | decrease | Depression severity measured with the SIGH-SAD | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | - | improved significantly | #1 |
light therapy | decrease | Depression severity measured with the SIGH-SAD | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | - | improved significantly | #2 |
CBT-SAD | decrease | Depression severity measured with the BDI-II | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | - | improved significantly | #3 |
light therapy | decrease | Depression severity measured with the BDI-II | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | - | improved significantly | #4 |
CBT-SAD | no change | remission rates based on the SIGH-SAD | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | 47.6% | did not differ in remission rates | #5 |
light therapy | no change | remission rates based on the SIGH-SAD | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | 47.2% | did not differ in remission rates | #6 |
CBT-SAD | no change | remission rates based on the BDI-II | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | 56.0% | did not differ in remission rates | #7 |
light therapy | no change | remission rates based on the BDI-II | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | 63.6% | did not differ in remission rates | #8 |
Having a baseline comorbid diagnosis | increase | depression scores | 177 adults with a current episode of major depression that was recurrent with a seasonal pattern | - | was associated with higher depression scores across all time points | #9 |
OBJECTIVE: Whereas considerable evidence supports light therapy for winter seasonal affective disorder (SAD), data on cognitive-behavioral therapy for SAD (CBT-SAD) are promising but preliminary. This study estimated the difference between CBT-SAD and light therapy outcomes in a large, more definitive test. METHOD: The participants were 177 adults with a current episode of major depression that was recurrent with a seasonal pattern. The randomized clinical trial compared 6 weeks of CBT-SAD (N=88) and light therapy (N=89). Light therapy consisted of 10,000-lux cool-white florescent light, initiated at 30 minutes each morning and adjusted according to a treatment algorithm based on response and side effects. CBT-SAD comprised 12 sessions of the authors' SAD-tailored protocol in a group format and was administered by Ph.D. psychologists in two 90-minute sessions per week. Outcomes were continuous scores on the Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD Version (SIGH-SAD, administered weekly) and Beck Depression Inventory-Second Edition (BDI-II, administered before treatment, at week 3, and after treatment) and posttreatment remission status based on cut points. RESULTS: Depression severity measured with the SIGH-SAD and BDI-II improved significantly and comparably with CBT-SAD and light therapy. Having a baseline comorbid diagnosis was associated with higher depression scores across all time points in both treatments. CBT-SAD and light therapy did not differ in remission rates based on the SIGH-SAD (47.6% and 47.2%, respectively) or the BDI-II (56.0% and 63.6%). CONCLUSIONS: CBT-SAD and light therapy are comparably effective for SAD during an acute episode, and both may be considered as treatment options.